OA07716A - Isoindoledicarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them. - Google Patents

Isoindoledicarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them.

Info

Publication number
OA07716A
OA07716A OA58310A OA58310A OA07716A OA 07716 A OA07716 A OA 07716A OA 58310 A OA58310 A OA 58310A OA 58310 A OA58310 A OA 58310A OA 07716 A OA07716 A OA 07716A
Authority
OA
OAPI
Prior art keywords
carbon atoms
formula
alkyl radical
see diagramm
compatible mineral
Prior art date
Application number
OA58310A
Other languages
French (fr)
Inventor
Michel Vincent
Georges Remond
Michel Laubie
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of OA07716A publication Critical patent/OA07716A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Compounds corresponding to the general formula I : see diagramm : EP0129461,P7,F5 in which the ring A is saturated or, alternatively, benzenic, R represents a hydrogen atom or a lower alkyl group having from 1 to 4 carbon atoms, R' represents a linear alkyl radical having from 1 to 6 carbon atoms or a mono- or di-cycloalkyl-alkyl radical having from 4 to 7 carbon atoms, in their racemic form or in the form of optical isomers, and the salts thereof obtained with a therapeutically compatible mineral or organic base or the addition salts thereof obtained with a pharmaceutically compatible mineral or organic acid. 1. Claim for the contracting state : AT Process for the preparation of compounds corresponding to the general formula I : see diagramm : EP0129461,P7,F6 in which the ring A is saturated or, alternatively, benzenic, R represents a hydrogen atom or a lower alkyl group having from 1 to 4 carbon atoms, R' represents a linear alkyl radical having from 1 to 6 carbon atoms or a mono- or di-cycloalkyl-alkyl radical having from 4 to 7 carbon atoms, in their racemic form or in the form of optical isomers, and the salts thereof obtained with a therapeutically compatible mineral or organic base or the addition salts thereof obtained with a pharmaceutically compatible mineral or organic acid, characterised in that a carboxyisoindole derivative of the formula : see diagramm : EP0129461,P8,F1 in which A has the same meaning as in formula I and R" represents an alkyl group having from 1 to 6 carbon atoms, preferably a tert.-butyl group, or one of the addition salts thereof, is condensed with a functional derivative of a substituted amino acid of the formula III : see diagramm : EP0129461,P8,F2 in which R et R' have the same meanings as in formula I and the nitrogen atom is protected by a radical customarily used for protection in the synthesis of peptides, such as benzyloxycarbonyl or tert.-butoxycarbonyl, and the intermediate compound obtained is subjected to customary deprotecting processes, such as, for example, total or partial saponification, and/or hydrogenolysis, and in this manner is converted into a compound of the formula I.
OA58310A 1983-06-06 1984-06-06 Isoindoledicarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them. OA07716A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8309326A FR2546886B2 (en) 1983-06-06 1983-06-06 DERIVATIVES OF ISOINDOLEDICARBOXYLIC ACIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
OA07716A true OA07716A (en) 1985-08-30

Family

ID=9289500

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58310A OA07716A (en) 1983-06-06 1984-06-06 Isoindoledicarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them.

Country Status (13)

Country Link
EP (1) EP0129461B1 (en)
JP (1) JPS6011467A (en)
AT (1) ATE25258T1 (en)
AU (1) AU566490B2 (en)
CA (1) CA1274347A (en)
DE (1) DE3462261D1 (en)
ES (1) ES8506623A1 (en)
FR (1) FR2546886B2 (en)
IE (1) IE57600B1 (en)
NZ (1) NZ208386A (en)
OA (1) OA07716A (en)
PT (1) PT78697A (en)
ZA (1) ZA844262B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000896A1 (en) * 1984-07-30 1986-02-13 Schering Corporation NOVEL PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA ADb BDPYRROLE-2-CARBOXYLATE
DE3640641A1 (en) * 1986-11-28 1988-07-14 Thomae Gmbh Dr K NEW HETEROAROMATIC AMINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
DK1603558T3 (en) 2003-02-28 2008-09-01 Servier S A Lab Process for the preparation of perindopril and its salts

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487829A2 (en) * 1979-12-07 1982-02-05 Science Union & Cie NOVEL SUBSTITUTED IMINO ACIDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
EP0278530A3 (en) * 1980-08-30 1989-08-02 Hoechst Aktiengesellschaft Amino acid derivatives, process for their preparation, agents containing them and their use
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
DE19575012I2 (en) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl dipeptides Process for their preparation and medicaments containing them
GB2086390B (en) * 1980-11-03 1984-06-06 Ciba Geigy Ag 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
DE3260423D1 (en) * 1981-02-17 1984-08-30 Warner Lambert Co Substituted acyl derivatives of octahydro-1h-isoindole-1-carboxylic acids and esters
JPS57158758A (en) * 1981-02-17 1982-09-30 Warner Lambert Co Substatuted acyl derivative of octahydro-1h- isoindole-1-carboxylic acid
EP0081094A1 (en) * 1981-11-12 1983-06-15 Merck & Co. Inc. Substituted omega-amino-carboxymethyldipeptide antihypertensive agents
US4431644A (en) * 1982-03-08 1984-02-14 Schering Corporation Antihypertensive agents
DE3211676A1 (en) * 1982-03-30 1983-10-06 Hoechst Ag NEW DERIVATIVES OF CYCLOALKA (C) PYRROL CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF, THEIR SUBSTANCES AND THE USE THEREOF AND NEW CYCLOALKA (C) PYRROL CARBONIC ACIDS AS THE INTERMEDIATE LEVELS AND METHODS
DE3315464A1 (en) * 1983-04-28 1984-10-31 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING N-ALKYLATED DIPEPTIDES AND THEIR ESTERS

Also Published As

Publication number Publication date
NZ208386A (en) 1989-01-27
EP0129461B1 (en) 1987-01-28
EP0129461A1 (en) 1984-12-27
CA1274347A (en) 1990-09-18
AU2915184A (en) 1984-12-20
FR2546886A2 (en) 1984-12-07
ES533174A0 (en) 1985-08-01
IE57600B1 (en) 1993-01-27
ES8506623A1 (en) 1985-08-01
AU566490B2 (en) 1987-10-22
ZA844262B (en) 1985-01-30
JPS6011467A (en) 1985-01-21
PT78697A (en) 1984-07-01
FR2546886B2 (en) 1986-05-16
DE3462261D1 (en) 1987-03-05
IE841386L (en) 1984-12-06
ATE25258T1 (en) 1987-02-15

Similar Documents

Publication Publication Date Title
LU90317I2 (en) Tacrolimus and its pharmaceutically acceptable salts and derivatives
EA199800394A1 (en) Pyrazolopyrimidines as CRF receptor antagonists
PT83521A (en) PROCESS FOR THE PREPARATION OF NOVEL NAPHTHALENIC BIBYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL AND COSMETIC COMPOSITIONS
EP0039051A3 (en) Mannich-base hydroxamic acid prodrugs for the improved delivery of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them
ES8306160A1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds.
ES8500903A1 (en) Indole-5-acetamides for treatment of migraine
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
EP0293771A3 (en) Cephalosporin compound and pharmaceutical composition thereof
EP0149487A3 (en) New cephem compounds, process for preparation thereof and pharmaceutical compositions containing them
PH24176A (en) New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same
DK607783A (en) NITROALIPHATIC COMPOUNDS
OA07716A (en) Isoindoledicarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them.
LV10235A (en) New esters are a method of obtaining a pharmaceutical composition for treating it
ATE59387T1 (en) 1,3-DIOXANE-4-YLALENE ACID.
DE69430766T2 (en) Vascular hypertrophic suppressor
ES8202003A1 (en) Ergoline derivatives, process for their preparation, and pharmaceutical compositions
GB1066266A (en) Diazepine derivatives
NZ234450A (en) Substituted pyrrolo(2,1-b)thiazole derivatives, intermediates and pharmaceutical compositions
GB889660A (en) Morphanthridine compounds
DE3063105D1 (en) Clavulanic acid derivatives, process for their preparation and pharmaceutical compositions containing them
TH919EX (en) Preparation of the derivative 1- alkyl-2-amino-tetralin
FR2317932A2 (en) INDOLOBENZAZEPINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB1032251A (en) Piperazine compounds and their preparation
AR003109A1 (en) COMPOUND WITH IMPORTANT ANTI-TUMOR ACTIVITY AND LOW TOXICITY AND SALT PHARMACEUTICALLY ACCEPTABLE COMPOSITE AND PHARMACEUTICAL COMPOSITION THAT LOCATES